{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T06:56:14Z","timestamp":1793084174214,"version":"4.5.0"},"reference-count":50,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2016,2,16]],"date-time":"2016-02-16T00:00:00Z","timestamp":1455580800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Brit J Clinical Pharma"],"published-print":{"date-parts":[[2016,5]]},"abstract":"<jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>The objective of this meta\u2010analysis was to determine whether gestational use of hydroxychloroquine (HCQ) for autoimmune disorders leads to an increase in the risk for adverse pregnancy outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      MEDLINE,\n                      <jats:styled-content style=\"fixed-case\">EMBASE<\/jats:styled-content>\n                      , Web of Science, and Cochrane Central Register of Controlled Trials databases were searched from inception to\n                      <jats:styled-content style=\"fixed-case\">November<\/jats:styled-content>\n                      21 2014. Studies which reported the outcomes of pregnant women after exposure to HCQ during pregnancy and including a control (unexposed) group were included. Two independent reviewers carried out the review and the quality assessment using the Methodological Index for Non\u2010Randomized Studies (MINORS). A random effects method was used to calculate the odds ratios (OR) for the outcomes.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The meta\u2010analysis reported no significant increases in rates of major congenital (OR 1.13, 95% confidence interval (CI) 0.59, 2.17), craniofacial (OR 0.62, 95% CI 0.13, 3.03), cardiovascular (OR 1.06, 95% CI 0.29, 3.86), genitourinary (OR 1.38, 95% CI 0.42, 4.53), nervous system malformations (OR 1.81, 95% CI 0.31, 10.52), stillbirth (OR 0.69, 95% CI 0.35, 1.34), low birth weight (OR 0.69, 95% CI 0.21, 2.27) or prematurity (OR 1.75, 95% CI 0.95, 3.24). The rate of spontaneous abortions, however, was found to be significantly increased in HCQ exposed pregnancies (OR 1.85, 95% CI 1.10, 3.13). No significant heterogeneity was detected among the studies for the evaluated outcomes except prematurity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Prenatal exposure to HCQ for autoimmune diseases does not appear to increase the risk of adverse pregnancy outcomes except spontaneous abortion rate, which may be associated with the underlying disease activity (bias by indication) and needs further investigation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/bcp.12872","type":"journal-article","created":{"date-parts":[[2015,12,23]],"date-time":"2015-12-23T17:12:50Z","timestamp":1450890770000},"page":"835-848","source":"Crossref","is-referenced-by-count":93,"title":["Reproductive outcomes following hydroxychloroquine use for autoimmune diseases: a systematic review and meta\u2010analysis"],"prefix":"10.1111","volume":"81","author":[{"given":"Yusuf Cem","family":"Kaplan","sequence":"first","affiliation":[{"name":"Terafar \u2010 Izmir Katip Celebi University Teratology Information Training and Research Center  Izmir Turkey"},{"name":"The Motherisk Program, Division of Clinical Pharmacology and Toxicology, Department of Pediatrics Hospital for Sick Children and University of Toronto  555 University Ave Toronto ON M5G 1X8"},{"name":"Izmir Katip Celebi Ataturk Egitim ve Arastirma Hastanesi Klinik Farmakoloji ve Toksikoloji Birimi  35360, Karabaglar Izmir Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jak","family":"Ozsarfati","sequence":"additional","affiliation":[{"name":"The Motherisk Program, Division of Clinical Pharmacology and Toxicology, Department of Pediatrics Hospital for Sick Children and University of Toronto  555 University Ave Toronto ON M5G 1X8"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheri","family":"Nickel","sequence":"additional","affiliation":[{"name":"Hospital Library &amp; Archives Hospital for Sick Children and University of Toronto  555 University Ave Toronto ON M5G 1X8 Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gideon","family":"Koren","sequence":"additional","affiliation":[{"name":"The Motherisk Program, Division of Clinical Pharmacology and Toxicology, Department of Pediatrics Hospital for Sick Children and University of Toronto  555 University Ave Toronto ON M5G 1X8"},{"name":"Leslie Dan Faculty of Pharmacy University of Toronto  144 College Street Toronto ON M5S 3M2"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2016,2,16]]},"reference":[{"issue":"3","key":"e_1_2_8_2_1","first-page":"iii30","article-title":"Connective tissue diseases and pregnancy","volume":"45","author":"Saar P","year":"2006","journal-title":"Rheumatology (Oxford)"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2011-154146"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/1756-185X.12524"},{"key":"e_1_2_8_5_1","first-page":"268","article-title":"Adverse pregnancy outcomes in women with systemic lupus erythematosus from a multiethnic US cohort: LUMINA (LVI) [corrected]","volume":"26","author":"Andrade R","year":"2008","journal-title":"Clin Exp Rheumatol"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1097\/BOR.0b013e328363ebf7"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1136\/lupus-2014-000020"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.rdc.2007.01.002"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1177\/0961203307086643"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-010-8243-x"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1517\/14740338.2011.566555"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2009.235"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199101173240303"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1191\/096120398678919778"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1177\/0961203307086503"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.lpm.2014.03.007"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2014.12.006"},{"key":"e_1_2_8_18_1","first-page":"387","article-title":"The risk of hospitalized infection in patients with rheumatoid arthritis","volume":"35","author":"Smitten AL","year":"2008","journal-title":"J Rheumatol"},{"key":"e_1_2_8_19_1","first-page":"300A","article-title":"Hydroxychloroquine prevents antiphospholipid antibody\u2010induced inhibition of trophoblast migration","volume":"20","author":"Albert CR","year":"2013","journal-title":"Reprod Sci"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/aji.12184"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/jth.12570"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2011.06.064"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.10150"},{"key":"e_1_2_8_24_1","doi-asserted-by":"publisher","DOI":"10.1038\/2271257a0"},{"key":"e_1_2_8_25_1","first-page":"466","article-title":"Retinal degeneration in two children following preventive antimalarial treatment of the mother during pregnancy","volume":"69","author":"Paufique L","year":"1969","journal-title":"Bull Soc Ophtalmol Fr"},{"key":"e_1_2_8_26_1","doi-asserted-by":"publisher","DOI":"10.1001\/archotol.1964.00750040419009"},{"key":"e_1_2_8_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(01)06004-4"},{"key":"e_1_2_8_28_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.11304"},{"key":"e_1_2_8_29_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.20648"},{"key":"e_1_2_8_30_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1651-2227.2009.01379.x"},{"key":"e_1_2_8_31_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1651-2227.2009.01523.x"},{"key":"e_1_2_8_32_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.55.7.486"},{"key":"e_1_2_8_33_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.11304"},{"key":"e_1_2_8_34_1","first-page":"755","article-title":"Hydroxychloroquine in pregnant patients with rheumatic disease: a case control observation of 76 treated pregnancies","volume":"13","author":"Frassi M","year":"2004","journal-title":"Lupus"},{"key":"e_1_2_8_35_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.22159"},{"key":"e_1_2_8_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.reprotox.2013.04.005"},{"key":"e_1_2_8_37_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.38262"},{"key":"e_1_2_8_38_1","doi-asserted-by":"crossref","first-page":"i55","DOI":"10.1093\/rheumatology\/keu095.004","article-title":"Longterm outcomes of children born to mothers with SLE exposed to hydroxychloroquine in pregnancy","volume":"53","author":"Gayed M","year":"2014","journal-title":"Rheumatology"},{"key":"e_1_2_8_39_1","doi-asserted-by":"publisher","DOI":"10.1191\/096120301678646137"},{"key":"e_1_2_8_40_1","doi-asserted-by":"publisher","DOI":"10.1186\/1546-0096-7-9"},{"key":"e_1_2_8_41_1","doi-asserted-by":"crossref","unstructured":"FinerLB ZolnaMR.Unintended pregnancy in theUnited States: incidence and disparities. Contraception2011;84:478\u201385.","DOI":"10.1016\/j.contraception.2011.07.013"},{"key":"e_1_2_8_42_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1445-2197.2003.02748.x"},{"key":"e_1_2_8_43_1","unstructured":"WellsG SheaB O'ConnellD PetersonJ WelchV LososM TugwellP. The Newcastle\u2010Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta\u2010analyses.2013. Available from:http:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.aspAcessed 2015 Dec 3."},{"key":"e_1_2_8_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/0197-2456(95)00134-4"},{"key":"e_1_2_8_45_1","unstructured":"The Cochrane Collaboration. Cochrane handbook for systematic reviews of interventions version 5.1.0.2011. Available athttp:\/\/www.cochrane\u2010handbook.org\/(last accessed 18November2015)."},{"key":"e_1_2_8_46_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.d5928"},{"key":"e_1_2_8_47_1","doi-asserted-by":"publisher","DOI":"10.1002\/sim.1186"},{"key":"e_1_2_8_48_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.333.7568.597"},{"key":"e_1_2_8_49_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2009.119263"},{"key":"e_1_2_8_50_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.111.089268"},{"key":"e_1_2_8_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0049-0172(95)80030-1"}],"container-title":["British Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fbcp.12872","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/bcp.12872","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,3]],"date-time":"2023-10-03T12:09:19Z","timestamp":1696334959000},"score":1,"resource":{"primary":{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/10.1111\/bcp.12872"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2,16]]},"references-count":50,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["10.1111\/bcp.12872"],"URL":"https:\/\/doi.org\/10.1111\/bcp.12872","archive":["Portico"],"relation":{},"ISSN":["0306-5251","1365-2125"],"issn-type":[{"value":"0306-5251","type":"print"},{"value":"1365-2125","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,16]]}}}